Sign inGet started

Bachrodt Amy

Insider CIK 2050422 · LYCA Chief Financial Officer, 10% owner · MAZE SVP, Finance

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LYCA Lycia Therapeutics, Inc. A Award deriv2026-08-112026-10-26399,746— $0399,746SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2026-04-012026-04-022,500— $033,833SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2026-04-012026-04-022,500$10.42 $26.1K15,465SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-04-012026-04-022,200$29.32 $64.5K13,265SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-04-012026-04-02300$30.34 $9.1K12,965SEC↗
MAZE Maze Therapeutics, Inc. A Award deriv2026-03-022026-03-0316,000— $016,000SEC↗
MAZE Maze Therapeutics, Inc. A Award deriv2026-03-022026-03-0332,000— $032,000SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2026-03-022026-03-035,000— $036,333SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-03-022026-03-033,700$45.47 $168.2K12,965SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-03-022026-03-031,300$44.44 $57.8K16,665SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2026-03-022026-03-035,000$10.42 $52.1K17,965SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2026-02-022026-02-04156— $041,333SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2026-02-022026-02-044,844— $03,025SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-02-022026-02-04200$44.15 $8.8K17,765SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2026-02-022026-02-044,844$10.42 $50.5K17,809SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2026-02-022026-02-04156$10.42 $1.6K17,965SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-02-022026-02-044,064$46.03 $187.1K13,701SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-02-022026-02-04736$46.63 $34.3K12,965SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2026-01-222026-01-262,497— $0486SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2026-01-222026-01-262,503— $07,869SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2026-01-222026-01-262,497$10.42 $26.0K15,462SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-01-222026-01-265,000$45.52 $227.6K12,965SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2026-01-222026-01-262,503$10.42 $26.1K17,965SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2026-01-022026-01-064,796— $02,983SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2026-01-022026-01-06204— $02,377SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2026-01-022026-01-06204$10.42 $2.1K13,169SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-01-022026-01-062,595$39.57 $102.7K12,965SEC↗
MAZE Maze Therapeutics, Inc. S Sale2026-01-022026-01-062,405$38.70 $93.1K15,560SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2026-01-022026-01-064,796$10.42 $50.0K17,965SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2025-12-302025-12-312,605— $02,581SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2025-12-302025-12-312,395— $01SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2025-12-302025-12-312,605$10.42 $27.1K17,965SEC↗
MAZE Maze Therapeutics, Inc. S Sale2025-12-302025-12-315,000$40.08 $200.4K12,965SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2025-12-302025-12-312,395$10.42 $25.0K15,360SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2025-12-292025-12-31124— $02,396SEC↗
MAZE Maze Therapeutics, Inc. M Exercise deriv2025-12-292025-12-319,876— $023,834SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2025-12-292025-12-31124$10.42 $1.3K13,089SEC↗
MAZE Maze Therapeutics, Inc. M Exercise2025-12-292025-12-319,876$10.42 $102.9K22,965SEC↗
MAZE Maze Therapeutics, Inc. S Sale2025-12-292025-12-319,400$40.54 $381.1K13,565SEC↗
MAZE Maze Therapeutics, Inc. S Sale2025-12-292025-12-31600$41.16 $24.7K12,965SEC↗
MAZE Maze Therapeutics, Inc. A Award deriv2025-09-222025-09-2422,000— $022,000SEC↗